• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于对比增强磁共振成像的深度学习模型用于预测肝细胞癌患者术后生存率

Deep learning model based on contrast-enhanced MRI for predicting post-surgical survival in patients with hepatocellular carcinoma.

作者信息

Ma Lidi, Li Congrui, Li Haixia, Zhang Cheng, Deng Kan, Zhang Weijing, Xie Chuanmiao

机构信息

Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, PR China.

Department of Diagnostic Radiology, Hunan Cancer Hospital, Central South University, Changsha, PR China.

出版信息

Heliyon. 2024 May 16;10(11):e31451. doi: 10.1016/j.heliyon.2024.e31451. eCollection 2024 Jun 15.

DOI:10.1016/j.heliyon.2024.e31451
PMID:38868019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11167253/
Abstract

OBJECTIVE

To develop a deep learning model based on contrast-enhanced magnetic resonance imaging (MRI) data to predict post-surgical overall survival (OS) in patients with hepatocellular carcinoma (HCC).

METHODS

This bi-center retrospective study included 564 surgically resected patients with HCC and divided them into training (326), testing (143), and external validation (95) cohorts. This study used a three-dimensional convolutional neural network (3D-CNN) ResNet to learn features from the pretreatment MR images (T1WIpre, late arterial phase, and portal venous phase) and got the deep learning score (DL score). Three cox regression models were established separately using the DL score (3D-CNN model), clinical features (clinical model), and a combination of above (combined model). The concordance index (C-index) was used to evaluate model performance.

RESULTS

We trained a 3D-CNN model to get DL score from samples. The C-index of the 3D-CNN model in predicting 5-year OS for the training, testing, and external validation cohorts were 0.746, 0.714, and 0.698, respectively, and were higher than those of the clinical model, which were 0.675, 0.674, and 0.631, respectively (P = 0.009, P = 0.204, and P = 0.092, respectively). The C-index of the combined model for testing and external validation cohorts was 0.750 and 0.723, respectively, significantly higher than the clinical model (P = 0.017, P = 0.016) and the 3D-CNN model (P = 0.029, P = 0.036).

CONCLUSIONS

The combined model integrating the DL score and clinical factors showed a higher predictive value than the clinical and 3D-CNN models and may be more useful in guiding clinical treatment decisions to improve the prognosis of patients with HCC.

摘要

目的

基于对比增强磁共振成像(MRI)数据开发一种深度学习模型,以预测肝细胞癌(HCC)患者术后的总生存期(OS)。

方法

这项双中心回顾性研究纳入了564例接受手术切除的HCC患者,并将他们分为训练组(326例)、测试组(143例)和外部验证组(95例)。本研究使用三维卷积神经网络(3D-CNN)ResNet从术前MR图像(T1WIpre、动脉晚期和门静脉期)中学习特征,并获得深度学习评分(DL评分)。分别使用DL评分(3D-CNN模型)、临床特征(临床模型)以及上述两者的组合建立了三个Cox回归模型。一致性指数(C指数)用于评估模型性能。

结果

我们训练了一个3D-CNN模型以从样本中获得DL评分。3D-CNN模型在预测训练组、测试组和外部验证组5年OS时的C指数分别为0.746、0.714和0.698,高于临床模型的C指数,临床模型的C指数分别为0.675、0.674和0.631(P分别为0.009、0.204和0.092)。测试组和外部验证组的联合模型的C指数分别为0.750和0.723,显著高于临床模型(P = 0.017,P = 0.016)和3D-CNN模型(P = 0.029,P = 0.036)。

结论

整合DL评分和临床因素的联合模型显示出比临床模型和3D-CNN模型更高的预测价值,可能在指导临床治疗决策以改善HCC患者的预后方面更有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/1519fecee225/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/0d8c0dff73e5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/9dd11583e38e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/342486c7599c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/20cefce4b7c9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/1519fecee225/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/0d8c0dff73e5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/9dd11583e38e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/342486c7599c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/20cefce4b7c9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6068/11167253/1519fecee225/gr5.jpg

相似文献

1
Deep learning model based on contrast-enhanced MRI for predicting post-surgical survival in patients with hepatocellular carcinoma.基于对比增强磁共振成像的深度学习模型用于预测肝细胞癌患者术后生存率
Heliyon. 2024 May 16;10(11):e31451. doi: 10.1016/j.heliyon.2024.e31451. eCollection 2024 Jun 15.
2
Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks.基于对比增强磁共振成像和三维卷积神经网络的肝细胞癌微血管侵犯预测
Front Oncol. 2021 Mar 4;11:588010. doi: 10.3389/fonc.2021.588010. eCollection 2021.
3
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.基于动态对比增强 MRI 联合临床参数的深度学习预测肝细胞癌微血管侵犯
J Cancer Res Clin Oncol. 2021 Dec;147(12):3757-3767. doi: 10.1007/s00432-021-03617-3. Epub 2021 Apr 10.
4
Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation.超声影像组学分析预测肝癌微波消融术后复发
Int J Hyperthermia. 2022;39(1):595-604. doi: 10.1080/02656736.2022.2062463.
5
Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors.基于对比增强多期磁共振成像的深度学习肝脏影像报告和数据系统(LI-RADS)分级系统用于鉴别LR-3与LR-4/LR-5级肝脏肿瘤
Ann Transl Med. 2020 Jun;8(11):701. doi: 10.21037/atm.2019.12.151.
6
Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.开发和验证 OSASH 评分以预测肝癌手术后的总生存:一项双机构研究。
Eur Radiol. 2023 Nov;33(11):7631-7645. doi: 10.1007/s00330-023-09725-7. Epub 2023 May 16.
7
Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.基于钆塞酸二钠增强 MRI 的深度学习列线图预测肝癌切除术后早期复发。
Eur Radiol. 2023 Jul;33(7):4949-4961. doi: 10.1007/s00330-023-09419-0. Epub 2023 Feb 14.
8
Deep Learning-Based Prediction of Post-treatment Survival in Hepatocellular Carcinoma Patients Using Pre-treatment CT Images and Clinical Data.基于深度学习利用治疗前CT图像和临床数据预测肝细胞癌患者治疗后的生存率
J Imaging Inform Med. 2025 Apr;38(2):1212-1223. doi: 10.1007/s10278-024-01227-2. Epub 2024 Aug 15.
9
A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.基于卷积神经网络,深入探究利用多参数磁共振成像进行肿瘤病灶分类。
Med Phys. 2020 Sep;47(9):4077-4086. doi: 10.1002/mp.14255. Epub 2020 Jun 12.
10
Prediction of microvascular invasion in hepatocellular carcinoma based on preoperative Gd-EOB-DTPA-enhanced MRI: Comparison of predictive performance among 2D, 2D-expansion and 3D deep learning models.基于术前钆塞酸二钠增强MRI预测肝细胞癌微血管侵犯:二维、二维扩展和三维深度学习模型预测性能的比较
Front Oncol. 2023 Feb 3;13:987781. doi: 10.3389/fonc.2023.987781. eCollection 2023.

引用本文的文献

1
Value of radiomics and deep learning feature fusion models based on dce-mri in distinguishing sinonasal squamous cell carcinoma from lymphoma.基于动态对比增强磁共振成像的影像组学和深度学习特征融合模型在鉴别鼻窦鳞状细胞癌与淋巴瘤中的价值
Front Oncol. 2024 Nov 21;14:1489973. doi: 10.3389/fonc.2024.1489973. eCollection 2024.

本文引用的文献

1
Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.基于术前增强 CT 的影像组学模型预测肝细胞癌患者总生存期。
World J Gastroenterol. 2022 Aug 21;28(31):4376-4389. doi: 10.3748/wjg.v28.i31.4376.
2
Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.预测肝细胞癌复发及患者术后总体生存的列线图
Front Oncol. 2022 Feb 28;12:843589. doi: 10.3389/fonc.2022.843589. eCollection 2022.
3
Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
纳入CNLC分期系统的列线图可预测肝细胞癌根治性切除术后的预后。
Front Oncol. 2022 Jan 21;11:755920. doi: 10.3389/fonc.2021.755920. eCollection 2021.
4
Saliency-based 3D convolutional neural network for categorising common focal liver lesions on multisequence MRI.基于显著性的3D卷积神经网络用于对多序列MRI上的常见肝脏局灶性病变进行分类
Insights Imaging. 2021 Nov 24;12(1):173. doi: 10.1186/s13244-021-01117-z.
5
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐:2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
6
Development of pre and post-operative nomograms to predict individual survival for ideal liver resection candidates with hepatocellular carcinoma.建立术前和术后列线图预测肝癌理想肝切除候选者的个体生存情况。
Liver Int. 2021 Dec;41(12):2974-2985. doi: 10.1111/liv.15042. Epub 2021 Sep 13.
7
Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy.预测根治性肝切除术后肝细胞癌患者总生存期的模型
Front Oncol. 2021 Mar 5;10:537526. doi: 10.3389/fonc.2020.537526. eCollection 2020.
8
A deep survival interpretable radiomics model of hepatocellular carcinoma patients.肝细胞癌患者深度生存可解释放射组学模型。
Phys Med. 2021 Feb;82:295-305. doi: 10.1016/j.ejmp.2021.02.013. Epub 2021 Mar 10.
9
Deep Learning With 3D Convolutional Neural Network for Noninvasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma.深度学习结合三维卷积神经网络无创预测肝细胞癌微血管侵犯。
J Magn Reson Imaging. 2021 Jul;54(1):134-143. doi: 10.1002/jmri.27538. Epub 2021 Feb 8.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.